LILLY BOURGUIGNON

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Hyaluronan-CD44 Interaction Promotes Oncogenic Signaling, microRNA Functions, Chemoresistance, and Radiation Resistance in Cancer Stem Cells Leading to Tumor Progression
    Lilly Y W Bourguignon
    Department of Medicine, University of California at San Francisco and Endocrine Unit 111N, VA Medical Center, San Francisco, California, USA Electronic address
    Adv Cancer Res 123:255-75. 2014
  2. pmc Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions
    Lilly Y W Bourguignon
    Department of Medicine, University of California at San Francisco, and the Endocrine Unit, VA Medical Center, San Francisco, California Electronic address
    Am J Pathol 184:1912-9. 2014
  3. pmc Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells
    Liqun Chen
    San Francisco Veterans Affairs Medical Center and Department of Medicine, University of California at San Francisco and Endocrine Unit 111N2, 4150 Clement Street, San Francisco, CA 94121, USA
    Mol Cancer 13:52. 2014
  4. pmc Selective matrix (hyaluronan) interaction with CD44 and RhoGTPase signaling promotes keratinocyte functions and overcomes age-related epidermal dysfunction
    Lilly Y W Bourguignon
    Department of Medicine, University of California San Francisco and VA Medical Center, United States Electronic address
    J Dermatol Sci 72:32-44. 2013
  5. pmc Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma
    Lilly Y W Bourguignon
    Endocrine Unit 111N2, Department of Medicine, University of California at San Francisco and Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Biol Chem 287:32800-24. 2012
  6. pmc Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression
    Lilly Y W Bourguignon
    Department of Medicine, University of California at San Francisco, and Endocrine Unit 111N2, VA Medical Center, San Francisco, CA USA
    Small Gtpases 3:53-9. 2012
  7. pmc Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells
    L Y W Bourguignon
    San Francisco Veterans Affairs Medical Center and Department of Medicine, University of California at San Francisco and Endocrine Unit 111N2, San Francisco, CA 94121, USA
    Oncogene 31:149-60. 2012
  8. pmc Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion
    Lilly Y W Bourguignon
    Department of Medicine, University of California, San Francisco, USA
    Cytoskeleton (Hoboken) 68:671-93. 2011
  9. pmc Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion
    Lilly Y W Bourguignon
    Department of Medicine, Endocrine Unit 111N, University of California at San Francisco and Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Biol Chem 285:36721-35. 2010
  10. pmc Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy res
    Lilly Y W Bourguignon
    Endocrine Unit, Department of Medicine, University of California at San Francisco, and Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Biol Chem 284:26533-46. 2009

Research Grants

Detail Information

Publications35

  1. ncbi request reprint Hyaluronan-CD44 Interaction Promotes Oncogenic Signaling, microRNA Functions, Chemoresistance, and Radiation Resistance in Cancer Stem Cells Leading to Tumor Progression
    Lilly Y W Bourguignon
    Department of Medicine, University of California at San Francisco and Endocrine Unit 111N, VA Medical Center, San Francisco, California, USA Electronic address
    Adv Cancer Res 123:255-75. 2014
    ..g., self-renewal, differentiation, and chemoresistance) during cancer progression. Understanding the regulation of CSCs is critically important for designing CSC-specific therapeutic targets to prevent cancer development and progression. ..
  2. pmc Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions
    Lilly Y W Bourguignon
    Department of Medicine, University of California at San Francisco, and the Endocrine Unit, VA Medical Center, San Francisco, California Electronic address
    Am J Pathol 184:1912-9. 2014
    ....
  3. pmc Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells
    Liqun Chen
    San Francisco Veterans Affairs Medical Center and Department of Medicine, University of California at San Francisco and Endocrine Unit 111N2, 4150 Clement Street, San Francisco, CA 94121, USA
    Mol Cancer 13:52. 2014
    ..This novel HA/CD44-mediated c-Jun signaling pathway and miR-21 production provide a new drug target for the future intervention strategies to treat breast cancer. ..
  4. pmc Selective matrix (hyaluronan) interaction with CD44 and RhoGTPase signaling promotes keratinocyte functions and overcomes age-related epidermal dysfunction
    Lilly Y W Bourguignon
    Department of Medicine, University of California San Francisco and VA Medical Center, United States Electronic address
    J Dermatol Sci 72:32-44. 2013
    ....
  5. pmc Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma
    Lilly Y W Bourguignon
    Endocrine Unit 111N2, Department of Medicine, University of California at San Francisco and Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Biol Chem 287:32800-24. 2012
    ..All of these events are critically important for the acquisition of cancer stem cell properties, including self-renewal, clonal formation, and chemotherapy resistance in HA-CD44v3-activated head and neck cancer...
  6. pmc Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression
    Lilly Y W Bourguignon
    Department of Medicine, University of California at San Francisco, and Endocrine Unit 111N2, VA Medical Center, San Francisco, CA USA
    Small Gtpases 3:53-9. 2012
    ..This new knowledge could serve as groundwork for the future development of new drug targets to inhibit HA/CD44-mediated oncogenic signaling and cancer progression...
  7. pmc Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells
    L Y W Bourguignon
    San Francisco Veterans Affairs Medical Center and Department of Medicine, University of California at San Francisco and Endocrine Unit 111N2, San Francisco, CA 94121, USA
    Oncogene 31:149-60. 2012
    ..This novel Nanog/Stat-3 signaling pathway-specific mechanism involved in miR-21 production is significant for the formation of future intervention strategies in the treatment of HA/CD44-activated HNSCC...
  8. pmc Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion
    Lilly Y W Bourguignon
    Department of Medicine, University of California, San Francisco, USA
    Cytoskeleton (Hoboken) 68:671-93. 2011
    ....
  9. pmc Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion
    Lilly Y W Bourguignon
    Department of Medicine, Endocrine Unit 111N, University of California at San Francisco and Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Biol Chem 285:36721-35. 2010
    ..All of these events are critical prerequisite steps for the acquisition of metastatic properties by human breast cancer cells...
  10. pmc Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy res
    Lilly Y W Bourguignon
    Endocrine Unit, Department of Medicine, University of California at San Francisco, and Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Biol Chem 284:26533-46. 2009
    ..Thus, this newly discovered HA-CD44 signaling pathway should provide important drug targets for sensitizing tumor cell apoptosis and overcoming chemotherapy resistance in breast cancer cells...
  11. pmc Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells
    Lilly Y W Bourguignon
    Department of Medicine, Endocrine Unit 111N2, University of California at San Francisco and Veterans Affairs Medical Center, San Francisco, CA 94121, USA
    J Biol Chem 284:2657-71. 2009
    ....
  12. pmc Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression
    Lilly Y W Bourguignon
    Department of Medicine, University of California at San Francisco and Endocrine Unit 111N, VA Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA
    Semin Cancer Biol 18:251-9. 2008
    ..It could also serve as ground work for the future development of new drug targets to inhibit HA/CD44-mediated tumor metastasis and cancer progression...
  13. pmc Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells
    Lilly Y W Bourguignon
    Department of Medicine, University of California, San Francisco, and Endocrine Unit, Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Biol Chem 283:17635-51. 2008
    ....
  14. ncbi request reprint Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration
    Lilly Y W Bourguignon
    Department of Medicine, University of California at San Francisco, USA
    J Biol Chem 282:19426-41. 2007
    ..Taken together, these findings clearly indicate that HRG activation of ErbB2-ERK signaling modulates HAS phosphorylation/activation and HA production leading to CD44-mediated oncogenic events and ovarian cancer progression...
  15. ncbi request reprint Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes
    Lilly Y W Bourguignon
    Department of Medicine, University of California San Francisco, Endocrine Unit 111 N, San Francisco VA Medical Center, San Francisco, CA 94121, USA
    J Neurochem 101:1002-17. 2007
    ..These newly discovered HA/CD44-induced astrocyte function may provide important insight into novel therapeutic treatments for tissue repair following CNS injury...
  16. ncbi request reprint Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells
    Lilly Y W Bourguignon
    Department of Medicine, University of California, Endocrine Unit, Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Biol Chem 282:1265-80. 2007
    ....
  17. pmc Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling
    Carlos Torre
    Department of Otolaryngology Head and Neck Surgery, University of California, San Francisco, San Francisco, CA 94121, USA
    Arch Otolaryngol Head Neck Surg 136:493-501. 2010
    ....
  18. ncbi request reprint CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration
    Patrick A Singleton
    Department of Medicine, University of California San Francisco, Endocrine Unit 111N, San Francisco VA Medical Center, 94121, USA
    Cell Motil Cytoskeleton 53:293-316. 2002
    ..Taken together, we believe that CD44v10 interaction with ROK plays a pivotal role in IP(3)R-mediated Ca(2+) signaling during HA-mediated endothelial cell migration...
  19. ncbi request reprint CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation
    Patrick A Singleton
    Endocrine Unit, Department of Medicine, University of California San Francisco and VA Medical Center, San Francisco, CA 94121, USA
    Exp Cell Res 295:102-18. 2004
    ....
  20. ncbi request reprint Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progressio
    Lilly Y W Bourguignon
    Department of Medicine, University of California at San Francisco and the Endocrine Unit 111N, Veterans Affairs Medical Center, San Francisco, Calfornia 94121, USA
    J Biol Chem 278:29420-34. 2003
    ..PI 3-kinase membrane localization, AKT signaling, and cytokine (M-CSF) production during HA-mediated breast cancer progression...
  21. ncbi request reprint Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells
    Lilly Y W Bourguignon
    Department of Medicine, University of California, San Francisco, and the Endocrine Unit, Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Biol Chem 277:39703-12. 2002
    ..g. Smad2/Smad3 phosphorylation and PTH-rP production) during HA and TGF-beta-mediated metastatic breast tumor progression...
  22. ncbi request reprint CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion
    Lilly Y W Bourguignon
    Department of Medicine, University of California, Veterans Affairs Medical Center, San Francisco 94121, USA
    J Biol Chem 279:26991-7007. 2004
    ....
  23. ncbi request reprint Hyaluronan-CD44 interaction with Rac1-dependent protein kinase N-gamma promotes phospholipase Cgamma1 activation, Ca(2+) signaling, and cortactin-cytoskeleton function leading to keratinocyte adhesion and differentiation
    Lilly Y W Bourguignon
    Department of Medicine, University of California, San Francisco, San Francisco Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Biol Chem 279:29654-69. 2004
    ....
  24. ncbi request reprint Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression
    Lilly Y W Bourguignon
    Department of Medicine, University of California, and the Endocrine Unit, Veterans Affair Medical Center, San Francisco, California 94121, USA
    J Biol Chem 280:11961-72. 2005
    ....
  25. ncbi request reprint Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer
    Steven J Wang
    Department of Otolaryngology Head and Neck Surgery, Veterans Affairs Medical Center, University of California, San Francisco, California, USA
    Head Neck 29:550-8. 2007
    ..The objective of this study was to investigate whether CD44 v3-containing isoforms are involved in head and neck squamous cell carcinoma (HNSCC) tumor progression...
  26. pmc Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-gamma1
    Zhongjian Xie
    Endocrine Unit, Veterans Affairs Medical Center, Northern California Institute for Research and Education and University of California San Francisco, San Francisco, CA 94121, USA
    Mol Biol Cell 16:3236-46. 2005
    ..These data indicate that calcium activates PLC-gamma1 via increased PIP3 formation mediated by c-src- and fyn-activated PI3K. This activation is required for calcium-induced human keratinocyte differentiation...
  27. ncbi request reprint Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer
    Steven J Wang
    Department of Otolaryngology Head and Neck Surgery, Veterans Affairs Medical Center, University of California, San Francisco, USA
    Arch Otolaryngol Head Neck Surg 132:771-8. 2006
    ..We recently determined that HA-CD44 promotes phospholipase C-mediated calcium signaling and cisplatin resistance in HNSCC...
  28. ncbi request reprint Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells
    Lilly Y W Bourguignon
    Department of Medicine, University of California at San Francisco and Endocrine Unit 111N, Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Biol Chem 281:14026-40. 2006
    ....
  29. ncbi request reprint Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer
    Steven J Wang
    Department of Otolaryngology Head and Neck Surgery and Endocrine Unit, Department of Medicine, University of California San Francisco, 4150 Clement Street 112B, San Francisco, CA 94121, USA
    Arch Otolaryngol Head Neck Surg 132:19-24. 2006
    ..To investigate whether hyaluronan (HA)-CD44 promotes head and neck squamous cell carcinoma (HNSCC) cisplatin resistance and whether HA-CD44 promotes phospholipase C (PLC)-mediated Ca2+ signaling to alter cisplatin sensitivity in HNSCC...
  30. pmc CD44 variant isoforms in head and neck squamous cell carcinoma progression
    Steven J Wang
    Department of Otolaryngology Head and Neck Surgery, University of California San Francisco, Veterans Affairs Medical Center, USA
    Laryngoscope 119:1518-30. 2009
    ..The objective of this study was to investigate the role of the CD44 v3, v6, and v10 variant isoforms in head and neck squamous cell carcinoma (HNSCC) tumor progression behaviors...
  31. ncbi request reprint Hyaluronan-CD44 interaction stimulates keratinocyte differentiation, lamellar body formation/secretion, and permeability barrier homeostasis
    Lilly Y W Bourguignon
    Department of Medicine, University of California San Francisco and VA Medical Center, San Francisco, California, USA lilly bourguignon ucsf edu
    J Invest Dermatol 126:1356-65. 2006
    ..HA-CD44 signaling could comprise a novel approach to treat skin disorders characterized by abnormalities in differentiation, lipid synthesis, and/or barrier function...
  32. ncbi request reprint Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44
    Jay J Cao
    Division of Endocrinology, Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Bone Miner Res 20:30-40. 2005
    ..HA stimulation of RANKL is blocked by anti-CD44 antibody and is absent in cells from CD44(-/-) mice. CD44(-/-) mice exhibit thicker cortical bone and a smaller medullary cavity, but indices of bone resorption are not affected...
  33. pmc Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord
    Jung Yu C Hsu
    Department of Neurological Surgery, University of California, San Francisco, California 94143, USA
    J Neurosci 28:13467-77. 2008
    ..MMP-9 may thus be a promising therapeutic target to reduce glial scarring during wound healing after spinal cord injury...
  34. pmc The role of CD44 in cutaneous inflammation
    Mona Man
    Department of Dermatology, University of California School of Medicine, San Francisco, CA, USA
    Exp Dermatol 18:962-8. 2009
    ....
  35. ncbi request reprint Signaling properties of hyaluronan receptors
    Eva A Turley
    London Regional Cancer Center, University of Western Ontario, London N6A 4L6, Canada
    J Biol Chem 277:4589-92. 2002

Research Grants26

  1. CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2002
    ..abstract_text> ..
  2. CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2003
    ..abstract_text> ..
  3. CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2004
    ..abstract_text> ..
  4. CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2004
    ..abstract_text> ..
  5. CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2005
    ..abstract_text> ..
  6. CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2006
    ..abstract_text> ..
  7. CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2006
    ....
  8. CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2007
    ..abstract_text> ..
  9. CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2007
    ....
  10. CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2009
    ....
  11. CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2003
    ..abstract_text> ..
  12. CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2002
    ....
  13. CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 1999
    ....
  14. CD44/VARIANT-CYTOSKELETON IN ADHESION AND BREAST CANCERS
    LILLY BOURGUIGNON; Fiscal Year: 1999
    ..The availability of antibodies against CD44v (unique for metastatic breast carcinomas) should prove to be very useful reagents for monitoring the progression and/or predicting the recurrence of metastatic breast carcinomas. ..
  15. CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2000
    ..abstract_text> ..
  16. CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2000
    ....
  17. CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2001
    ....
  18. CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2001
    ..abstract_text> ..
  19. CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2001
    ..abstract_text> ..
  20. CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSION
    LILLY BOURGUIGNON; Fiscal Year: 2001
    ....
  21. CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSION
    LILLY YW BOURGUIGNON; Fiscal Year: 2010
    ....